Nanostring Technologies Inc 's ability to collect accounts receivable sequentially worsen to 4.12, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Nanostring Technologies Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 89 days, from 87 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 250 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 1999.

What is Receivable Turnover Ratio?
What is Nanostring Technologies Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NSTG Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	77.29 %	36.87 %	14.77 %	-21.49 %	-23.11 %
Y / Y Revenue Change	62.79 %	37.05 %	15.2 %	-18.92 %	-20.48 %
Receivable Turnover Ratio (TTM)	4.12	4.21	4.22	4.22	4.19
NSTG's Total Ranking	# 1999	# 1999	# 2457	# 1996	# 1376
Accounts Receivable average collection period days	89	87	86	86	87
Seq. Receivable Change	12.49 %	23.27 %	10.67 %	15.52 %	-13.15 %
Seq. Revenue Change	8.9 %	23.33 %	4.02 %	16.52 %	-8.31 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 17
Healthcare Sector	# 251
Overall Market	# 1999

Receivable Turnover Ratio Statistics
High	Average	Low
0.96	0.56	0.28
(Sep 30 2018)		(Jun 30 2021)

NSTG Company Profile • Back to NSTG Efficiency Comparisons • Compare NSTG Receivables Turnover Ratio to its Competitors

Financial Statements
Nanostring Technologies Inc 's Accounts Receivable	$ 48 Millions	Visit NSTG's Balance sheet
Nanostring Technologies Inc 's Sales TTM	$ 162 Millions	Visit NSTG's Income Statement
Sources of NSTG's Revenues		Visit NSTG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NSTG's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NSTG's Growth Rates	NSTG's Roa	NSTG's Inventory Turnover Ratio	NSTG's Dividend Comparisons
NSTG's Profitability Ratios	NSTG's Roi	NSTG's Asset Turnover Ratio	NSTG's Dividend Growth
NSTG's Valuation Ratios	NSTG's Roe	NSTG's Financial Strength Ratios	NSTG's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Tvardi Therapeutics Inc	9.20	$ 21.225 Millions	$ 2.308 Millions
Acorda Therapeutics Inc	9.18	$ 111.118 Millions	$ 12.106 Millions
Harmony Biosciences Holdings inc	9.09	$ 541.622 Millions	$ 59.598 Millions
Myomo Inc	9.08	$ 17.258 Millions	$ 1.901 Millions
Igc Pharma Inc	9.04	$ 1.343 Millions	$ 0.149 Millions
Talis Biomedical Corporation	9.04	$ 2.196 Millions	$ 0.243 Millions
Emmaus Life Sciences Inc	8.94	$ 28.460 Millions	$ 3.185 Millions
Inspire Medical Systems inc	8.90	$ 569.809 Millions	$ 63.988 Millions
Avid Bioservices Inc	8.90	$ 139.466 Millions	$ 15.678 Millions
Biodesix Inc	8.87	$ 44.026 Millions	$ 4.966 Millions
Sanara Medtech Inc	8.83	$ 61.677 Millions	$ 6.987 Millions
Insmed Inc	8.76	$ 277.639 Millions	$ 31.691 Millions
Scientific Industries Inc	8.74	$ 11.043 Millions	$ 1.264 Millions
Arcturus Therapeutics Holdings Inc	8.70	$ 296.237 Millions	$ 34.067 Millions
Immucell Corporation	8.69	$ 15.668 Millions	$ 1.803 Millions
Addus Homecare Corp	8.64	$ 1,028.360 Millions	$ 119.076 Millions
Adapthealth Corp	8.62	$ 3,122.226 Millions	$ 362.205 Millions
Celldex Therapeutics inc	8.60	$ 4.365 Millions	$ 0.508 Millions
Zymeworks Inc	8.53	$ 461.579 Millions	$ 54.102 Millions
Henry Schein Inc	8.53	$ 12,693.000 Millions	$ 1,488.250 Millions
Acadia Healthcare Company Inc	8.49	$ 2,923.743 Millions	$ 344.337 Millions
Adma Biologics Inc	8.48	$ 233.238 Millions	$ 27.518 Millions
Lensar Inc	8.47	$ 40.291 Millions	$ 4.758 Millions
Clearpoint Neuro Inc	8.45	$ 22.319 Millions	$ 2.641 Millions
Lumos Pharma Inc	8.39	$ 1.737 Millions	$ 0.207 Millions
Silk Road Medical Inc	8.36	$ 169.880 Millions	$ 20.317 Millions
Harrow Inc	8.29	$ 114.100 Millions	$ 13.772 Millions
Ati Physical Therapy Inc	8.26	$ 678.488 Millions	$ 82.158 Millions
Pulmatrix Inc	8.25	$ 6.804 Millions	$ 0.824 Millions
AnTix Holdings, Inc.	8.23	$ 1.821 Millions	$ 0.221 Millions

Date modified: 2026-08-29T17:23:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.